Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunome (IMNM) Shares Issued (2023 - 2025)

Immunome (IMNM) has disclosed Shares Issued for 3 consecutive years, with $45.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Issued rose 182.11% year-over-year to $45.9 million, compared with a TTM value of $45.9 million through Dec 2025, up 129.48%, and an annual FY2025 reading of $45.9 million, up 129.48% over the prior year.
  • Shares Issued was $45.9 million for Q4 2025 at Immunome, up from -$428000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $125.0 million in Q2 2023 and bottomed at -$428000.0 in Q3 2025.
  • Average Shares Issued over 3 years is $17.4 million, with a median of $337000.0 recorded in 2023.
  • The sharpest move saw Shares Issued surged 4727.6% in 2024, then tumbled 115.85% in 2025.
  • Year by year, Shares Issued stood at $337000.0 in 2023, then soared by 4727.6% to $16.3 million in 2024, then skyrocketed by 182.11% to $45.9 million in 2025.
  • Business Quant data shows Shares Issued for IMNM at $45.9 million in Q4 2025, -$428000.0 in Q3 2025, and $215000.0 in Q2 2025.